In this Pipeline Accelerator round, Phenomics Australia is partnering with Therapeutic innovation Australia (TIA), ANSTO’s National Deuteration Facility (NDF) and Bioplatforms Australia (BPA) to expand the list of translation expertise necessary for the discovery and translation of medical research. This scheme aims to support therapeutic development projects by providing up to $50,000 with at least 50% matching funding (co-investment) by the applicant. We are pleased to announce the expansion of this scheme to include subsidised access to new facilities (MMIC, ABInitio)
Applications close on Friday 2nd of May 2025, 5pm (AEST).
Info Session
Please note our webinar is postponed due to tropical cyclone Alfred